摘要
长链非编码RNA(long non-coding RNA,lncRNA)与肿瘤的发生发展密切相关。LncRNA反义Opa反应蛋白5RNA(Opa interacting protein 5-antisense RNA 1,OIP5-AS1)在多种肿瘤中不仅异常表达,还发挥癌基因的作用,是潜在的肿瘤治疗靶点,并有望成为肿瘤诊断和预后新的标志物。本文就近年来OIP5-AS1在肿瘤中作用的相关研究作一综述,以期为OIP5-AS1的临床应用提供依据。
Long non-coding RNA(lncRNA)is closely associated with the occurrence and development of tumors.LncRNA Opa interacting protein 5-antisense RNA 1(OIP5-AS1)is not only abnormally expressed in a variety of tumors,but also acts as an oncogene.It is a potential tumor for treatment target which is expected to become a new marker for tumor diagnosis and prognosis.In this essay,we will provide a brief overview of the recent relevant studies on the function of OIP5-AS1 in tumors with a view to providing evidence for its clinical use.
作者
李晓丹
方学红
蒋代顺
林杰(综述)
刘义
邹丽宜(审校)
LI Xiaodan;FANG Xuehong;JIANG Daishun;LIN Jie;LIU Yi;ZOU Liyi(School of Pharmacy,Guangdong Medical University(Dongguan Campus),Dongguan Guangdong 523808;School of Pharmacy,Guangdong Medical University(Zhanjiang Campus),Zhanjiang Guangdong 524023;Guangdong Key Laboratory for Research and Development of Natural Drugs,Guangdong Medical University,Zhanjiang Guangdong 524023;Marine Medicine Research Institute,Guangdong Medical University,Zhanjiang Guangdong 524023,China)
出处
《临床与病理杂志》
CAS
2022年第4期962-968,共7页
Journal of Clinical and Pathological Research
基金
国家自然科学基金(82073054)。